Mallory Ursul

Associate

Mallory is temporarily on a full-time client secondment.

Mallory Ursul
  • JD, summa cum laude, Suffolk University Law School, 2020; Note Editor, Suffolk University Law Review;  Legal Innovation & Technology Fellow, Suffolk University Law School Health Law Clinic
  • BS, magna cum laude, Loyola University Chicago, 2015

Qualifications

  • Massachusetts, 2021

Mallory Ursul

Associate

Mallory is temporarily on a full-time client secondment.

Mallory Ursul practices in the intellectual property transactions group and advises public and private companies, investors, entrepreneurs, and other clients on a wide range of strategic transactions, including license agreements, complex collaborations, mergers and acquisitions, supply and distribution agreements, and other commercial transactions where intellectual property is a key consideration. Mallory has represented clients in a variety of industries including life sciences, technology, software, and consumer products.

Experience

  • Advised clinical stage precision cancer biopharmaceutical company IDRx in licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to secure rights to IDRX-42 and IDRX-73- two small molecule tyrosine kinase inhibitors.
  • Advised Ginkgo Bioworks, a horizontal platform for cell programming, in an agreement with Bayer to expand Ginkgo’s platform capabilities in agricultural biologicals.

Publications

  • Co-author, “Life Sciences U.S. Trends and Developments,”  Chambers Global Practice Guide 2022 chapter (April 2022)
    • JD, summa cum laude, Suffolk University Law School, 2020; Note Editor, Suffolk University Law Review;  Legal Innovation & Technology Fellow, Suffolk University Law School Health Law Clinic
    • BS, magna cum laude, Loyola University Chicago, 2015

    Qualifications

    • Massachusetts, 2021
    Cookie Settings